Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.

BCR-ABL1 transcripts chronic myeloid leukemia discontinuation relapse-free survival response to imatinib survival

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
16 Jul 2021
Historique:
received: 15 06 2021
revised: 12 07 2021
accepted: 13 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 25 7 2021
Statut: epublish

Résumé

The most frequent

Identifiants

pubmed: 34300312
pii: jcm10143146
doi: 10.3390/jcm10143146
pmc: PMC8307111
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Blood. 1990 May 15;75(10):2035-41
pubmed: 2337672
Eur J Haematol. 2019 Sep;103(3):272-273
pubmed: 31233644
Genet Mol Res. 2008 Oct 21;7(4):1138-49
pubmed: 19048492
Clin Lymphoma Myeloma Leuk. 2017 Nov;17(11):728-733
pubmed: 28822797
Leukemia. 2020 Apr;34(4):1052-1061
pubmed: 31768016
Blood. 2013 Aug 8;122(6):872-84
pubmed: 23803709
Haematologica. 2017 Oct;102(10):1704-1708
pubmed: 28838993
Leukemia. 1990 Dec;4(12):839-42
pubmed: 2173804
Leukemia. 2019 May;33(5):1173-1183
pubmed: 30675008
Blood. 2017 Mar 2;129(9):1166-1176
pubmed: 28049640
Blood Cancer J. 2018 Dec 2;8(10):91
pubmed: 30504932
Genet Mol Res. 2005 Dec 30;4(4):803-11
pubmed: 16475128
Cancer. 2019 May 15;125(10):1674-1682
pubmed: 30707758
Oncotarget. 2017 Dec 26;9(7):7534-7540
pubmed: 29484130
Blood. 2009 Jun 18;113(25):6315-21
pubmed: 19369233
Haematologica. 2014 Sep;99(9):1441-7
pubmed: 24837466
Br J Haematol. 1990 Jan;74(1):30-5
pubmed: 2310695
Leukemia. 2014 Oct;28(10):1988-92
pubmed: 24798484
Br J Haematol. 1995 Mar;89(3):546-54
pubmed: 7734353
Leuk Res. 2021 Feb;101:106512
pubmed: 33524640
Leukemia. 2019 Oct;33(10):2358-2364
pubmed: 31455852
Exp Mol Pathol. 2015 Aug;99(1):16-8
pubmed: 25913326
Eur J Haematol. 2016 Apr;96(4):360-6
pubmed: 26059983
Blood. 2011 Jul 21;118(3):686-92
pubmed: 21536864
Eur J Cancer. 2000 Jul;36(11):1395-401
pubmed: 10899653
Blood. 1991 Sep 1;78(5):1155-61
pubmed: 1878582
Haematologica. 2009 Oct;94(10):1362-7
pubmed: 19713230
Leuk Res. 2010 Oct;34(10):1255-68
pubmed: 20537386
Blood. 2000 Nov 15;96(10):3343-56
pubmed: 11071626
Med Sci Monit. 2002 May;8(5):BR193-7
pubmed: 12011769
Am J Hematol. 2017 Aug;92(8):797-805
pubmed: 28466557
Blood. 1984 Apr;63(4):789-99
pubmed: 6584184
Br J Haematol. 1998 Oct;103(1):224-6
pubmed: 9792313
Eur J Haematol. 2019 Jul;103(1):26-34
pubmed: 30985947
Blood. 2016 Mar 10;127(10):1269-75
pubmed: 26729897

Auteurs

Sílvia Marcé (S)

Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.

Blanca Xicoy (B)

Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.

Olga García (O)

Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.

Marta Cabezón (M)

Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.

Natalia Estrada (N)

Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.

Patricia Vélez (P)

Hematology Department, ICO Hospitalet-Hospital Duran y Reynals, 08908 l'Hospitalet de Llobregat, Spain.

Concepción Boqué (C)

Hematology Department, ICO Hospitalet-Hospital Duran y Reynals, 08908 l'Hospitalet de Llobregat, Spain.

Miguel Sagüés (M)

Hematology Department, ICO Girona-Hospital Josep Trueta, 17007 Girona, Spain.

Anna Angona (A)

Hematology Department, ICO Girona-Hospital Josep Trueta, 17007 Girona, Spain.

Raúl Teruel-Montoya (R)

Hematology-Oncology Department, Hospital General Universitario Morales Meseguer-CIBERER, UCAM, 30008 Murcia, Spain.

Francisca Ferrer-Marín (F)

Hematology-Oncology Department, Hospital General Universitario Morales Meseguer-CIBERER, UCAM, 30008 Murcia, Spain.

Paula Amat (P)

Hematology Department, Hospital Clínico Universitario-INCLIVA de Valencia, 46010 Valencia, Spain.

Juan Carlos Hernández-Boluda (JC)

Hematology Department, Hospital Clínico Universitario-INCLIVA de Valencia, 46010 Valencia, Spain.

Mariana M Ibarra (MM)

Hematology Department, Hospital Clínico San Carlos (HCSC), Instituto de Medicina de Laboratorio (IML), Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.

Eduardo Anguita (E)

Hematology Department, Hospital Clínico San Carlos (HCSC), Instituto de Medicina de Laboratorio (IML), Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.

Montserrat Cortés (M)

Hematology Department, Hospital General de Granollers, 08402 Granollers, Spain.

Andrés Fernández-Ruiz (A)

Hematology Department, ICO Hospitalet-Hospital Duran y Reynals, 08908 l'Hospitalet de Llobregat, Spain.

Sandra Fontanals (S)

Pharmaceutics Department, ICO Hospitalet-Hospital Duran y Reynals, 08908 l'Hospitalet de Llobregat, Spain.

Lurdes Zamora (L)

Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.

Classifications MeSH